Singapore markets open in 17 minutes

Nabriva Therapeutics plc (NBRVF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 11:09AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
29,387
35,668
27,216
2,864
7,748
Cost of revenue
34,277
28,581
13,148
766
70
Gross profit
-4,890
7,087
14,068
2,098
7,678
Operating expenses
Research development
10,369
14,263
12,630
15,102
26,415
Selling general and administrative
34,624
45,264
51,645
55,285
62,485
Total operating expenses
44,823
58,260
62,596
68,224
87,167
Operating income or loss
-49,713
-51,173
-48,528
-66,126
-79,489
Interest expense
-
698
901
1,649
3,644
Total other income/expenses net
-4,032
-3,746
469
-1,570
215
Income before tax
-54,224
-55,617
-48,960
-69,345
-82,663
Income tax expense
830
1,568
490
139
101
Income from continuing operations
-55,054
-57,185
-49,450
-69,484
-82,764
Net income
-55,054
-57,185
-49,450
-69,484
-82,764
Net income available to common shareholders
-55,054
-57,185
-49,450
-69,484
-82,764
Basic EPS
-18.37
-21.32
-28.52
-135.23
-278.75
Diluted EPS
-18.37
-21.32
-28.52
-135.23
-278.75
Basic average shares
3,075
2,682
1,734
513.804
296.797
Diluted average shares
3,075
2,682
1,734
513.804
296.797